Source: Health Canada shortage reports · Updated Jul 9, 2026
Tolterodine is in a widespread shortage in Canada. 8 of 16 reported products are affected. The latest manufacturer estimate for full recovery is Sep 8, 2026.
A bladder medication used to treat overactive bladder symptoms such as frequent or urgent urination.
Products affected
8 / 16
In shortage since
Oct 4, 2023
Est. full return
Sep 8, 2026
Reports on file
81
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DETROL
1MG · TABLET · BGP PHARMA ULC
DIN 02239064 · since Dec 30, 2025, no end estimate · Demand increase for the drug.
Active shortage
JAMP TOLTERODINE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02496844 · since Oct 31, 2025, est. end Aug 14, 2026 · Demand increase for the drug.
DIN 02413140 · ended Apr 13, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Tolterodine is currently affected by 8 active shortage reports filed with Health Canada by BGP PHARMA ULC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Tolterodine is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).
Recent changes
No changes recorded yet.
Common questions
What is Tolterodine used for?
A bladder medication used to treat overactive bladder symptoms such as frequent or urgent urination.
When will Tolterodine be back in stock in Canada?
The latest manufacturer estimate is Sep 8, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Tolterodine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.